|
|
||||||||
1 Universitätsklinikum Eppendorf, 20246 Hamburg, Germany; 2 Division of Nephrology, Department of Medicine, Veterans Affairs Medical Center, and 3 Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37212-2372
The
Cre/loxP transgenic system may be used to achieve temporally
and/or spatially regulated gene deletion. The Mx1Cre
mouse expresses Cre recombinase under control of the IFN-inducible
Mx1 promoter. Mx1Cre mice were crossed with a
reporter strain (ROSA26tm1Sor) in which
-galactosidase activity is
expressed only after Cre-mediated recombination to determine
the cellular pattern of Cre-mediated genetic recombination
in the kidney and other tissues. Widespread recombination was observed
in vascular endothelium as well as in the liver and spleen.
Recombination was restricted to subsets of stromal cells in uterus,
duodenum, colon, aorta, and kidney. In the cortex,
-galactosidase
activity was detected in a subset of tubules and all glomerular cells,
including endothelium, mesangium, and podocytes. No
-galactosidase
activity was detected in proximal tubules. Costaining of kidneys with
segment-specific markers demonstrated induction of
-galactosidase
activity in collecting duct, with sporadic labeling of the thick
ascending limb but no significant labeling of distal convoluted
tubules. We conclude that Mx1-driven gene recombination is
spatially as well as temporally restricted. The Mx1Cre
transgene should prove a useful reagent to achieve temporally regulated
recombination in endothelial, glomerular, and distal renal epithelia in mice.
Cre recombinase; liver; spleen; interstitium; collecting duct; glomerulus
This article has been cited by other articles:
![]() |
S. L. Siggins, N.-Y N. Nguyen, M. P. McCormack, S. Vasudevan, R. Villani, S. M. Jane, B. J. Wainwright, and D. J. Curtis The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms Blood, July 30, 2009; 114(5): 995 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Morris and A. I. McClatchey Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma PNAS, June 16, 2009; 106(24): 9767 - 9772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Salmon, N. J. Slater, M. A. Hall, M. P. McCormack, S. L. Nutt, S. M. Jane, and D. J. Curtis Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene Blood, November 15, 2007; 110(10): 3573 - 3581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Bleuming, X. C. He, L. L. Kodach, J. C. Hardwick, F. A. Koopman, F. J. ten Kate, S. J.H. van Deventer, D. W. Hommes, M. P. Peppelenbosch, G. J. Offerhaus, et al. Bone Morphogenetic Protein Signaling Suppresses Tumorigenesis at Gastric Epithelial Transition Zones in Mice Cancer Res., September 1, 2007; 67(17): 8149 - 8155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gawlik and S. E. Quaggin Deciphering the Renal Code: Advances in Conditional Gene Targeting Physiology, October 1, 2004; 19(5): 245 - 252. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |